Skip to content

60 DEGREES PHARMACEUTICALS, INC.: 10-Q filed 2023-08-25

What 60 DEGREES PHARMACEUTICALS, INC. reported in its quarterly report filed 2023-08-25 (fiscal Q2 2023): 47 published measures, 132 facts as tagged in accession 0001213900-23-070884.

This filing

Form
10-Q (quarterly report)
Filed
2023-08-25
Fiscal period
fiscal Q2 2023
Accession
0001213900-23-070884 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All 60 DEGREES PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-06-307,358,738USD
At 2022-12-311,297,206USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-06-3030,235,587USD
At 2022-12-3125,446,266USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-06-30-22,300,020USD
At 2022-12-31-23,576,740USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-3,336,555USD91
2023-01-01 to 2023-06-30-5,936,616USD181
2022-04-01 to 2022-06-30-2,146,899USD91
2022-01-01 to 2022-06-30-3,059,181USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-726,168USD181
2022-01-01 to 2022-06-30-636,944USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2023-04-01 to 2023-06-3059,532USD91
2023-01-01 to 2023-06-3076,704USD181
2022-04-01 to 2022-06-3045,173USD91
2022-01-01 to 2022-06-3092,197USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-01-01 to 2023-06-30503,456USD181
2022-01-01 to 2022-06-301,290,335USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-21,419USD181
2022-01-01 to 2022-06-30-2,907USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-06-30-34,751,764USD
At 2022-12-31-28,815,148USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-04-01 to 2023-06-302,378,009shares91
2023-01-01 to 2023-06-302,341,274shares181
2022-04-01 to 2022-06-302,349,349shares91
2022-01-01 to 2022-06-302,349,147shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2023-04-01 to 2023-06-302,378,009shares91
2023-01-01 to 2023-06-302,341,274shares181
2022-04-01 to 2022-06-302,349,349shares91
2022-01-01 to 2022-06-302,349,147shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-1.4USD/shares91
2023-01-01 to 2023-06-30-2.54USD/shares181
2022-04-01 to 2022-06-30-0.96USD/shares91
2022-01-01 to 2022-06-30-1.31USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-1.4USD/shares91
2023-01-01 to 2023-06-30-2.54USD/shares181
2022-04-01 to 2022-06-30-0.96USD/shares91
2022-01-01 to 2022-06-30-1.31USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2023-04-01 to 2023-06-3063USD91
2023-01-01 to 2023-06-30126USD181
2022-04-01 to 2022-06-30250USD91
2022-01-01 to 2022-06-30500USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2023-06-307,498USD
At 2022-12-3121,300USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-01-01 to 2023-06-30277,605USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-787,996USD91
2023-01-01 to 2023-06-30-1,738,660USD181
2022-04-01 to 2022-06-30-686,919USD91
2022-01-01 to 2022-06-30-850,631USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-06-305,674,701USD
At 2022-12-311,099,004USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-04-01 to 2023-06-301,099,656USD91
2023-01-01 to 2023-06-302,241,085USD181
2022-04-01 to 2022-06-30905,519USD91
2022-01-01 to 2022-06-301,667,736USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-06-3028,862,838USD
At 2022-12-3123,921,211USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2023-06-30125,470USD
At 2022-12-3145,965USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-04-01 to 2023-06-30666,667USD91
2023-01-01 to 2023-06-301,565,675USD181
2022-04-01 to 2022-06-30637,232USD91
2022-01-01 to 2022-06-30874,981USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2023-06-30465,515USD
At 2022-12-31518,578USD

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2023-04-01 to 2023-06-30183,977USD91
2023-01-01 to 2023-06-30257,097USD181
2022-04-01 to 2022-06-3087,120USD91
2022-01-01 to 2022-06-30177,254USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2023-04-01 to 2023-06-30203,872USD91
2023-01-01 to 2023-06-30327,866USD181
2022-04-01 to 2022-06-30231,394USD91
2022-01-01 to 2022-06-30294,451USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-06-302,378,009shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2023-06-3019,070USD
At 2022-12-31264,865USD
At 2022-06-30751,450USD
At 2021-12-31115,399USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-06-3012,379,462USD
At 2022-12-315,164,461USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2023-06-3072,044USD
At 2022-12-3173,708USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2023-06-30-22,876,849USD
At 2023-03-31-19,532,884USD
At 2022-12-31-24,149,060USD
At 2022-06-30-21,041,045USD
At 2022-03-31-18,965,375USD
At 2021-12-31-18,154,484USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2023-06-3039,070USD
At 2022-12-3112,647USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2023-06-3039,470USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2023-06-30150,000USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2023-06-30148,202USD
At 2022-12-31148,202USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2023-06-30140,704USD
At 2022-12-31126,902USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2023-06-30206,377USD
At 2022-12-31164,255USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2023-06-301,100,000USD
At 2022-12-310USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-3,343,528USD91
2023-01-01 to 2023-06-30-5,940,999USD181
2022-04-01 to 2022-06-30-2,149,766USD91
2022-01-01 to 2022-06-30-3,056,963USD181

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-3,343,591USD91
2023-01-01 to 2023-06-30-5,941,125USD181
2023-01-01 to 2023-03-31-2,597,534USD90
2022-04-01 to 2022-06-30-2,150,016USD91
2022-01-01 to 2022-06-30-3,057,463USD181
2022-01-01 to 2022-03-31-907,447USD90

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-3,336,929USD91
2023-01-01 to 2023-06-30-5,938,280USD181
2022-04-01 to 2022-06-30-2,257,888USD91
2022-01-01 to 2022-06-30-3,073,614USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2023-04-01 to 2023-06-30462,795USD91
2023-01-01 to 2023-06-301,237,809USD181
2022-04-01 to 2022-06-30405,838USD91
2022-01-01 to 2022-06-30580,530USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2023-04-01 to 2023-06-306,901USD91
2023-01-01 to 2023-06-3013,802USD181
2022-04-01 to 2022-06-306,901USD91
2022-01-01 to 2022-06-3013,846USD181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2023-04-01 to 2023-06-306,017USD91
2023-01-01 to 2023-06-3013,192USD181
2022-04-01 to 2022-06-30952USD91
2022-01-01 to 2022-06-301,962USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2022-11-01 to 2022-11-04731USD4

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2022-01-01 to 2022-06-30185,335USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-06-3079,505USD181
2022-01-01 to 2022-06-30-96,030USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-762USD181
2022-01-01 to 2022-06-3056,986USD181

Inspect the source

Entity
60 DEGREES PHARMACEUTICALS, INC. / CIK 0001946563
Captured
2026-09-21T17:41:45.368Z
SEC response SHA-256
b95fff66e7a953f292c25a6ce30bc53c9746adb7dec7916bb5971972be8b9ae4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001946563.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))